Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,835 | 197 | 85.6% |
| Travel and Lodging | $602.51 | 4 | 13.4% |
| Education | $25.25 | 2 | 0.6% |
| Gift | $16.94 | 17 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,085 | 61 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $797.25 | 5 | $0 (2017) |
| ABBVIE INC. | $550.33 | 25 | $0 (2024) |
| ASCEND THERAPEUTICS US, LLC | $206.41 | 26 | $0 (2023) |
| Orexigen Therapeutics, Inc. | $146.49 | 10 | $0 (2017) |
| Currax Pharmaceuticals LLC | $136.79 | 9 | $0 (2024) |
| Eisai Inc. | $134.98 | 9 | $0 (2021) |
| PFIZER INC. | $130.71 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $121.30 | 6 | $0 (2023) |
| Galderma Laboratories, L.P. | $121.28 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $355.07 | 18 | Novo Nordisk Inc ($105.31) |
| 2023 | $513.85 | 27 | MAYNE PHARMA COMMERCIAL LLC ($107.91) |
| 2022 | $604.70 | 51 | ASCEND Therapeutics US, LLC ($136.79) |
| 2021 | $720.09 | 39 | Novo Nordisk Inc ($257.62) |
| 2020 | $160.47 | 9 | Galderma Laboratories, L.P. ($44.69) |
| 2019 | $62.44 | 4 | AbbVie, Inc. ($37.81) |
| 2018 | $521.64 | 35 | AbbVie, Inc. ($158.78) |
| 2017 | $1,541 | 37 | BOSTON SCIENTIFIC CORPORATION ($797.25) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | MILLICENT US INC | INTRAROSA (Drug), FEMRING | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 12/10/2024 | MILLICENT US INC | — | Education | In-kind items and services | $13.35 | General |
| 12/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Obesity | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Obesity | ||||||
| 08/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Obesity | ||||||
| 07/15/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Obesity | ||||||
| 07/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: PAIN | ||||||
| 05/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Obesity | ||||||
| 05/08/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Obesity | ||||||
| 03/25/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Obesity | ||||||
| 03/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Obesity | ||||||
| 02/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Obesity | ||||||
| 01/30/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: WOMENS HEALTH | ||||||
| 01/29/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Obesity | ||||||
| 01/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Obesity | ||||||
| 12/05/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $4.85 | General |
| 11/15/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $30.95 | General |
| 11/01/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Biological | ||||||
| 10/17/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $8.57 | General |
| 09/14/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Obesity | ||||||
| 09/12/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Biological | ||||||
About Dr. James Carr, MD
Dr. James Carr, MD is a Gynecology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316918238.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Carr, MD has received a total of $4,480 in payments from pharmaceutical and medical device companies, with $355.07 received in 2024. These payments were reported across 220 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,835).
Practice Information
- Specialty Gynecology
- Location Raleigh, NC
- Active Since 01/30/2006
- Last Updated 05/08/2019
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1316918238
Products in Payments
- GENERAL - PELVIC ORGAN PROLAPSE (Device) $427.68
- Wegovy (Drug) $423.76
- GENERAL - FEMALE SUI (Device) $369.57
- Saxenda (Drug) $339.14
- CONTRAVE (Drug) $249.96
- ESTROGEL (Drug) $206.41
- Victoza (Drug) $159.73
- Belviq (Drug) $121.64
- Axonics r-SNM System (Device) $108.61
- PREMARIN (Drug) $104.75
- ZEPBOUND (Drug) $84.86
- MYFEMBREE (Drug) $84.03
- LO LOESTRIN FE (Drug) $76.68
- Veozah (Drug) $74.67
- ORIAHNN (Drug) $73.62
- QULIPTA (Drug) $70.64
- APLENZIN (Drug) $68.70
- TROKENDI XR (Drug) $64.84
- Orilissa (Drug) $60.24
- UBRELVY (Drug) $59.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecology Doctors in Raleigh
Dr. Pouru Bhiwandi, M. D, M. D
Gynecology — Payments: $205,159
Dr. Jerome Gardner, Md, MD
Gynecology — Payments: $108,885
Dr. Lisa Roberts, M.d, M.D
Gynecology — Payments: $6,082
Rosemarie Newman, Md, MD
Gynecology — Payments: $3,745
Dr. Marianna Law, Md, MD
Gynecology — Payments: $2,608
Dr. Elizabeth Roede Barbee, M.d, M.D
Gynecology — Payments: $1,052